Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000418799 | SCV000515295 | likely benign | not specified | 2018-03-08 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001457225 | SCV001661024 | likely benign | Mowat-Wilson syndrome | 2022-11-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002446658 | SCV002736515 | likely benign | Inborn genetic diseases | 2018-07-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV001457225 | SCV002807064 | likely benign | Mowat-Wilson syndrome | 2022-04-04 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003992290 | SCV004811443 | likely benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | ZEB2: BP4, BP7 |
Prevention |
RCV003972582 | SCV004793846 | likely benign | ZEB2-related disorder | 2019-02-21 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |